# A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

> **NCT00506207** · PHASE1 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 23 (actual)

## Conditions studied

- Colorectal Neoplasm
- Gastric Neoplasm
- Secondary

## Interventions

- **DRUG:** S-1, Irinotecan, Oxaliplatin

## Key facts

- **NCT ID:** NCT00506207
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2007-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506207, "A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00506207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*